Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | GLB1 | P16278 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10191062 | 0.86 | HPGD (0.39) | CA2CA1CA9ALDH1A1GLB1 | |
| SCHEMBL8008682 | 0.84 | CA2 (0.36) | CA2CA1CA9 | |
| SCHEMBL10191037 | 0.79 | CA2 (0.37) | CA2CA1CA9ALDH1A1 | |
| SCHEMBL8005469 | 0.79 | CA2 (0.37) | CA2CA1CA9ALDH1A1 | |
| SCHEMBL10191077 | 0.77 | CA2 (0.34) | CA2CA1CA9ALDH1A1 | |
| SCHEMBL10190947 | 0.76 | CA2 (0.33) | CA2CA1CA9ALDH1A1 | |
| SCHEMBL10190980 | 0.76 | HPGD (0.34) | CA2CA1CA9ALDH1A1 | |
| SCHEMBL10191009 | 0.75 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL8008365 | 0.75 | CA2 (0.32) | CA2CA1CA9ALDH1A1 | |
| SCHEMBL21148820 | 0.73 | DRD4 (0.41) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120040897-A1 | NOVEL DERIVATIVES OF ACYL CYANOPYRROLIDINES | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) | 2012-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120040897-A1 | NOVEL DERIVATIVES OF ACYL CYANOPYRROLIDINES | NR1D2, STARD10, NR1D1 | CA2 894/4885CA1 2022/4885CA9 1253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.